Fundraising Fox
Inventiva
Founded 2012 · 126 employees on LinkedIn · 9 known investors
Find your way into Inventiva
Sign up to see every warm intro you have to Inventiva
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inventiva team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.
Investors · 9
How we know: the company's own site · Not right? Tell us
How we know: Claret Capital Partners's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · Not right? Tell us
How we know: funding news · biocentury.com · Not right? Tell us
How we know: funding news · biocentury.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountprivate placementApr 2018
BVF Partners, Novo Holdings A/S, Sofinnova Crossover I fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Inventiva.
Frequently asked questions
- What does Inventiva do?
- Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.
- Who are Inventiva's investors?
- Inventiva's investors include European Investment Bank, Andera Partners, Claret Capital Partners, New Enterprise Associates (NEA), Samsara BioCapital, Sofinnova Partners, Biotechnology Value Fund, Novo Holdings.